These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18837949)

  • 41. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
    Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
    Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
    Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
    Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
    BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical relevance of circulating nucleosomes in cancer.
    Holdenrieder S; Nagel D; Schalhorn A; Heinemann V; Wilkowski R; von Pawel J; Raith H; Feldmann K; Kremer AE; Müller S; Geiger S; Hamann GF; Seidel D; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():180-9. PubMed ID: 18837945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
    Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
    Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-surface-bound nucleic acids: Free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients.
    Laktionov PP; Tamkovich SN; Rykova EY; Bryzgunova OE; Starikov AV; Kuznetsova NP; Vlassov VV
    Ann N Y Acad Sci; 2004 Jun; 1022():221-7. PubMed ID: 15251964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma DNA levels in spiral CT-detected and clinically detected lung cancer patients: a validation analysis.
    Roz L; Verri C; Conte D; Miceli R; Mariani L; Calabro' E; Andriani F; Pastorino U; Sozzi G
    Lung Cancer; 2009 Nov; 66(2):270-1. PubMed ID: 19744743
    [No Abstract]   [Full Text] [Related]  

  • 51. [Free circulating DNA as a tool for lung cancer patients management].
    Tissot C; Villar S; Olivier M; Couraud S
    Rev Pneumol Clin; 2016 Feb; 72(1):61-71. PubMed ID: 26190335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Free circulating DNA: good as a diagnostic marker in lung cancer?
    Altundag O; Altundag K; Altundag M
    J Clin Oncol; 2004 Aug; 22(15):3201-2; author reply 3202. PubMed ID: 15284278
    [No Abstract]   [Full Text] [Related]  

  • 53. Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats.
    García-Olmo DC; Samos J; Picazo MG; Asensio AI; Toboso I; García-Olmo D
    Cancer Lett; 2008 Dec; 272(1):133-40. PubMed ID: 18707808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular circulating nucleic acids in human plasma in health and disease.
    Laktionov PP; Tamkovich SN; Rykova EY; Bryzgunova OE; Starikov AV; Kuznetsova NP; Sumarokov SV; Kolomiets SA; Sevostianova NV; Vlassov VV
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):879-83. PubMed ID: 15560076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The struggle to detect circulating DNA.
    Zeerleder S
    Crit Care; 2006; 10(3):142. PubMed ID: 16719935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic tests: unreliable for cancer? A focus on circulating DNA and lung cancer.
    Teare MD; Woll PJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):699-702. PubMed ID: 18020899
    [No Abstract]   [Full Text] [Related]  

  • 57. [Share of extracellular mutated mitochondrial DNA increases in plasma of lung cancer patients following radiotherapy].
    Strelkova IIu; Abdullaev SA; Snigireva GP; Bezlepkin VG; Gaziev AI
    Biomed Khim; 2010; 56(4):517-25. PubMed ID: 21032903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble interleukin-2 receptor: a new prognostic marker in lung cancer.
    Marino P; Buccheri G; Preatoni A; Ferrigno D; Cori P; Rosti A; Mozzi R; Moroni GA
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):151-4. PubMed ID: 2092110
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pulmonary cancer cells in the circulating blood. I. Position of the problem. Clinical study].
    Martin-Lalande J; Durand G; Le Mauff JM; Carraud J
    J Fr Med Chir Thorac; 1971; 25(2):179-91. PubMed ID: 5553096
    [No Abstract]   [Full Text] [Related]  

  • 60. [Ultra-weak luminescence of blood in cancer patients].
    Mi FS
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):436-8. PubMed ID: 1576910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.